Amylyx director granted 24,372 stock options
Amylyx Pharmaceuticals director Karen Firestone received a grant of stock options covering 24,372 shares of common stock at an exercise price of $14.31 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amylyx Pharmaceuticals director Karen Firestone received a grant of stock options covering 24,372 shares of common stock at an exercise price of $14.31 per share. These options vest in full on the earlier of June 4, 2027 or the next annual meeting, provided she remains in continuous service, and bring her directly held option position reported in this filing to 24,372 shares.
Insider Trade Summary
Grant/Award: 24,372 shares
Grant/Award
1 txn
Insider
Firestone Karen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 24,372 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 24,372 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
Option grant size: 24,372 shares
Exercise price: $14.31 per share
Post-grant options held: 24,372 options
+2 more
5 metrics
Option grant size
24,372 shares
Stock Option (right to buy) granted to director
Exercise price
$14.31 per share
Conversion or exercise price of stock option
Post-grant options held
24,372 options
Total shares following transaction, direct ownership
Option expiration
June 3, 2036
Expiration date of the stock option grant
Underlying shares
24,372 common shares
Underlying Amylyx common stock for the option
Key Terms
Stock Option (right to buy), Common Stock, exercise price, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: "14.3100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-03T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest in full financial
"The shares subject to this option shall vest in full upon the earlier of"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amylyx Pharmaceuticals (AMLX) director Karen Firestone report on this Form 4?
Karen Firestone reported receiving a grant of stock options for 24,372 Amylyx common shares. The options were awarded at an exercise price of $14.31 per share as compensation, not through an open-market stock purchase or sale.
What is the size and exercise price of the Amylyx (AMLX) stock options granted to Karen Firestone?
The grant covers 24,372 shares of Amylyx common stock with an exercise price of $14.31 per share. This means she can buy those shares at $14.31 once the options vest, regardless of the future market price.
When do Karen Firestone’s Amylyx (AMLX) stock options vest?
The options vest in full on the earlier of June 4, 2027 or the date of the next annual meeting. Vesting is conditioned on her continuous service with Amylyx through that vesting date, according to the filing footnote.
How many Amylyx (AMLX) options does Karen Firestone hold after this transaction?
After this grant, the Form 4 shows Karen Firestone holding 24,372 stock options directly. These options are all tied to Amylyx common stock and reflect compensation-based equity rather than shares acquired on the open market.
Is Karen Firestone’s Amylyx (AMLX) Form 4 transaction a stock purchase or sale?
The transaction is a grant of stock options, not a market trade. The Form 4 uses code “A” for a grant, award, or other acquisition, meaning she received options as compensation instead of buying or selling existing shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates